Sign in
4

Changes in Ownership

ADMA BIOLOGICS, INC. Filed Acc 0001140361-26-008905

COO and SVP, Compliance sold 10,096 shares at $15.63 ($157,800)

  • COO and SVP, Compliance gave up 14,294 shares (to pay taxes)
  • COO and SVP, Compliance acquired 10,096 shares (option exercise)
  • COO and SVP, Compliance disposed of 91,266 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Kestenberg-Messina Kaitlin M. · COO and SVP, Compliance

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-06 Shares withheld for taxes : show line 1 in the form −10,059 $15.39 $154,808 562,101 D
2026-03-07 Shares withheld for taxes : show line 2 in the form −4,235 $15.39 $65,177 557,866 D
2026-03-09 Other disposition : show line 3 in the form −91,266 466,600 D
2026-03-09 Exercise or conversion : show line 4 in the form +2,500 $5.00 $12,500 469,100 D
2026-03-09 Exercise or conversion : show line 5 in the form +1,250 $4.31 $5,388 470,350 D
2026-03-09 Exercise or conversion : show line 6 in the form +2,646 $2.83 $7,488 472,996 D
2026-03-09 Exercise or conversion : show line 7 in the form +1,525 $2.35 $3,584 474,521 D
2026-03-09 Exercise or conversion : show line 8 in the form +2,175 $1.55 $3,371 476,696 D
2026-03-09 Sale : show line 9 in the form −10,096 $15.63 $157,800 466,600 D
Open-market sales · 10,096 sh · avg $15.63 · $157,800

Table II: Derivative

5 lines
Date Transaction Shares Owned after D/I
2026-03-09 Exercise or conversion : show line 10 in the form Stock Option (right to buy) −2,500 2,500 D
2026-03-09 Exercise or conversion : show line 11 in the form Stock Option (right to buy) −1,250 1,250 D
2026-03-09 Exercise or conversion : show line 12 in the form Stock Option (right to buy) −2,646 2,771 D
2026-03-09 Exercise or conversion : show line 13 in the form Stock Option (right to buy) −1,525 2,225 D
2026-03-09 Exercise or conversion : show line 14 in the form Stock Option (right to buy) −2,175 2,825 D
Loading xslF345X05/form4.xml…